Steven Andrew Baker (Steven A Baker, Steven Baker)

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 6

Top Topics

Sickle Cell Disease

Angiotensin Converting Enzyme

Mechanical Ventilation

Top Venues

Case reports in medicine

Research and practice in thrombosis and haemostasis

This page only lists publications with an associated author ORCID identifier.

Publications

Hunter D Montgomery, Matthew X Luo, Steven Andrew Baker, Ming Y Lim
An Unusual Case of Hyperhemolysis Syndrome and Delayed Hemolytic Transfusion Reaction due to Anti-Jk(a) and Anti-P1 Antibodies. Case reports in medicine 2023 (2023)
Hunter D Montgomery, Matthew X Luo, Steven Andrew Baker, Ming Y Lim
An Unusual Case of Hyperhemolysis Syndrome and Delayed Hemolytic Transfusion Reaction due to Anti-Jk(a) and Anti-P1 Antibodies. Case reports in medicine 2023 (2023)
Steven Andrew Baker, Lisa Kanata Wong, Rebekah Wieland, Philip Bulterys, Libby Allard, Lang Nguyen, Thinh Quach, AnhThu Nguyen, Eunkyong Chaesuh, Phil Cheng, Raffick Bowen, Mrigender Singh Virk
Validated transport conditions maintain the quality of washed red blood cells. Transfusion 62 (9) (2022)
Steven Andrew Baker, Jing Jin, Christopher Pfaffroth, Trang Vu, James L Zehnder
DOAC-Stop in lupus anticoagulant testing: Direct oral anticoagulant interference removed in most samples. Research and practice in thrombosis and haemostasis 5 (2) (2021)
Steven Andrew Baker, Shirley Kwok, Gerald J Berry, Thomas J Montine
Angiotensin-converting enzyme 2 (ACE2) expression increases with age in patients requiring mechanical ventilation. PloS one 16 (2) (2021)
Laura M Lombardi, Manar Zaghlula, Yehezkel Sztainberg, Steven Andrew Baker, Tiemo J Klisch, Amy A Tang, Eric J Huang, Huda Yaya Zoghbi
An RNA interference screen identifies druggable regulators of MeCP2 stability. Science translational medicine 9 (404) (2018)